Kristina Cutter
About Kristina Cutter
Kristina Cutter: Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
Kristina Cutter holds the position of Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer. She is responsible for overseeing regulatory strategies, ensuring the safety monitoring of pharmaceutical products, and maintaining quality assurance practices within her organization. Her role is critical in navigating the complex regulatory environment and ensuring compliance with industry standards and regulations.
Kristina Cutter's Education and Expertise
Kristina Cutter graduated from the University of Michigan School of Public Health with a Master’s degree in Public Health. Her education provided her with a strong foundation in public health principles, epidemiology, and regulatory affairs. This academic background has equipped her with the necessary skills to excel in the pharmaceutical and healthcare industry.
Kristina Cutter's Career Background in the Pharmaceutical Industry
Kristina Cutter began her pharmaceutical career by auditing neurology clinical trials for Parke-Davis. Early in her career, she transitioned into project management of large epidemiological studies. Her extensive experience includes a stint in Commercial Regulatory Affairs at Pfizer, where she focused on the regulatory promotion of women's health, cardiovascular, and oncology products. This diverse background has allowed her to gain significant expertise across various therapeutic areas.
Therapeutic Areas and Companies Kristina Cutter Has Contributed To
Throughout her career, Kristina Cutter has worked across numerous therapeutic areas, from IND to commercialization. She has contributed her expertise to several prominent pharmaceutical companies, including Amgen, Genentech/Roche, Intermune, and Halozyme. Her work spans a wide array of therapeutic areas, reflecting her comprehensive understanding of the pharmaceutical development process.